InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Misajon Pamela. Director active across 1 company, notably Kiromic Biopharma, Inc.. Aggregated, 3 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €8k. Activity tracked since 10 June 2024. The latest transaction was filed on 12 June 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations